Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Apothca, Inc. Set to Open the First Medical Marijuana Dispensary in Lynn, Massachusetts
  • USA - English

Apothca, Inc. is opening the first medical marijuana dispensary in the City of Lynn on Friday, November 16, 2018


News provided by

Apothca, Inc.

Nov 15, 2018, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Apothca Logo
Apothca Logo

LYNN, Mass., Nov. 15, 2018 /PRNewswire-PRWeb/ -- Apothca, Inc., is set to open Lynn's first Registered Marijuana Dispensary ("RMD") at 491 Lynnway, Lynn, Massachusetts 01905 on Friday, November 16, 2018.

This is Apothca's second medical marijuana dispensary in Massachusetts with the first location, in Arlington, MA, located at 11 Water Street, Unit 3b (third floor), having opened on October 26, 2018.

Apothca is launching new special pricing programs and promotions for the benefit of Massachusetts medical marijuana patients. Apothca will offer the same promotions in both the Lynn and Arlington cannabis dispensaries. Starting November 16, 2018, Apothca's promotions will include:

  • New Medical Patient Card: All patients receiving their new or renewed Massachusetts medical program cards will be eligible to receive $200 in discounts on their purchases at Apothca's Massachusetts locations.
  • New Apothca Patient Card: All patients who visit an Apothca dispensary for the first time will be eligible to receive $100 in discounts on their purchases at Apothca's Massachusetts locations.
  • Patient Referral Program: Any Apothca patient who brings a new patient for their first visit to an Apothca location in Massachusetts is eligible to receive a $50 discount on their purchase that visit.

The terms and conditions of Apothca's promotions can be seen at http://www.apothca.com.

"Apothca would like to thank the Lynn community and all Lynn City officials for the opportunity to serve the medical marijuana needs of Lynn patients and those of the surrounding communities," said Joseph Lekach, co-founder of Apothca, Inc. "We are excited and humbled to be the first cannabis dispensary to open in the City of Lynn and we hope to work closely with our neighbors to make sure the patient experience is nothing short of extraordinary," continued Mr. Lekach.

With Apothca's 4,600 square foot flagship retail location and ample parking directly on the Lynnway, the patient experience in Lynn's Apothca will be unrivaled in the Commonwealth of Massachusetts.

Patients will have access to a wide variety of medical cannabis products including flower, concentrates, pre-rolled joints, edibles, tinctures, and full spectrum CBD products in an opening and welcoming atmosphere.

Apothca, Inc has received a Special Permit from the Lynn City Council to operate an Adult-Use Retail Marijuana Dispensary and plans to locate a dual-use medical and adult-use cannabis dispensary at the same 491 Lynnway location. "We are waiting for the Cannabis Control Commission to issue a Retail Marijuana License. As soon as they do, we will be ready to serve all guests in the same store. We have built our Lynn location to comply with both the Department of Public Health and Cannabis Control Commission regulations. Our Fitchburg cultivation campus is currently working hard to prepare enough cannabis products to serve all patients and guests," added Lekach.

Apothca, Inc. currently operates the first climate-controlled greenhouse for marijuana cultivation in its 26 acre Fitchburg cannabis campus, a former Bayer Pharmaceuticals facility.

Apothca, Inc. plans to open its third location in Boston, Massachusetts' neighborhood of Jamaica Plain in early 2019.

About Apothca, Inc

Apothca, Inc. is a vertically integrated cannabis company operating in Massachusetts, Oregon, and Colombia.

Apothca, Inc. currently has two dispensaries in Massachusetts, located at 11 Water St, Unit 3b (third floor), Arlington, Massachusetts 02476 and 491 Lynnway, Lynn, Massachusetts 10905. Our state-of-the-art cannabis cultivation campus is in Fitchburg, Massachusetts with the first ever cannabis greenhouse in Massachusetts.

Apothca, Inc. also has a retail operation in Eugene, Oregon and is launching a cultivation, extraction, research, and export operations in the country of Colombia.

For more information on Apothca, Inc., its operations, or its team, please visit http://www.apothca.com.

For all inquiries, please email [email protected].

SOURCE Apothca, Inc.

Related Links

https://apothca.com/

Modal title

Overhead View of Apothca's Greenhouse
Overhead View of Apothca's Greenhouse
Overhead View of Apothca's Cultivation Campus
Overhead View of Apothca's Cultivation Campus
Cannabis Flowering
Cannabis Flowering
Overhead View of Apothca's Greenhouse Overhead View of Apothca's Cultivation Campus Cannabis Flowering

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.